$2.91
▼ -2.7% Today
as of Jul 22, 16:52 ET
Last 30 days
Recent Press Releases & News
NSRX: NS002 June KOL Event
Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum
Nasus Pharma Says Intranasal NS003 Shows Positive Preclinical Results
Overview
52-week range
$1.98
$9.99
12% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for NSRX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.